相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment
Wen Yue et al.
CANCER PREVENTION RESEARCH (2014)
Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stress
Jun-gang Zhang et al.
CANCER SCIENCE (2014)
Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
Zheng Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Targeting mTOR dependency in pancreatic cancer
Douglas C. Morran et al.
GUT (2014)
Radiosensitization of Pancreatic Cancer Cells by Metformin through the AMPK Pathway
Aisha Fasih et al.
RADIATION RESEARCH (2014)
Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
Kaixin Zhou et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Association of metformin use with cancer incidence and mortality: A meta-analysis
Pengpeng Zhang et al.
CANCER EPIDEMIOLOGY (2013)
Pharmacogenetic Variation and Metformin Response
Suning Chen et al.
CURRENT DRUG METABOLISM (2013)
A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth
Yuqing Zhang et al.
EMBO MOLECULAR MEDICINE (2013)
Metformin and Survival in Pancreatic Cancer
Allen L. Hwang et al.
PANCREAS (2013)
Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells
Enza Lonardo et al.
PLOS ONE (2013)
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
Altaf Mohammed et al.
TRANSLATIONAL ONCOLOGY (2013)
Use of Antidiabetic Agents and the Risk of Pancreatic Cancer: A Case-Control Analysis
Michael Bodmer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Metformin and Pancreatic Cancer: A Clue Requiring Investigation
Michael Pollak
CLINICAL CANCER RESEARCH (2012)
Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
Navid Sadeghi et al.
CLINICAL CANCER RESEARCH (2012)
Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells
Weiguang Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
Davide Soranna et al.
ONCOLOGIST (2012)
Metformin pathways: pharmacokinetics and pharmacodynamics
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2012)
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study
Lei Kong et al.
ACTA DIABETOLOGICA (2011)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Interactions of Tyrosine Kinase Inhibitors with Organic Cation Transporters and Multidrug and Toxic Compound Extrusion Proteins
Tsuyoshi Minematsu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus
T. Krechler et al.
NEOPLASMA (2011)
Metabolic Disorder, Inflammation, and Deregulated Molecular Pathways Converging in Pancreatic Cancer Development: Implications for New Therapeutic Strategies
Yoshiharu Motoo et al.
Cancers (2011)
MicroRNA in pancreatic cancer: Pathological, diagnostic and therapeutic implications
Satyanarayana Rachagani et al.
CANCER LETTERS (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
被撤回的出版物: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF (Retracted article. See vol. 78, pg. 5466, 2018)
Shadan Ali et al.
CANCER RESEARCH (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Diabetes Mellitus in Pancreatic Cancer and the Need for Diagnosis of Asymptomatic Disease
A. Bartosch-Harlid et al.
PANCREATOLOGY (2010)
A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells
Oliver A. Kent et al.
CANCER BIOLOGY & THERAPY (2009)
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study
Maria Dalamaga et al.
CANCER CAUSES & CONTROL (2009)
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth
Krisztina Kisfalvi et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Role and therapeutic potential of microRNAs in diabetes
I. G. M. Kolfschoten et al.
DIABETES OBESITY & METABOLISM (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Peter Olson et al.
GENES & DEVELOPMENT (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Alterations in microRNA expression contribute to fatty acid-induced pancreatic β-cell dysfunction
Pascal Lovis et al.
DIABETES (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic β-cells through restoration of mitochondrial electron transfer
S. A. Hinke et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine
Mingyan Zhou et al.
DRUG METABOLISM AND DISPOSITION (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
microRNAs as oncogenes and tumor suppressors
Baohong Zhang et al.
DEVELOPMENTAL BIOLOGY (2007)
The energy sensing LKB1-AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis
Jiyong Liang et al.
NATURE CELL BIOLOGY (2007)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)
J Müller et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Insulinand its receptor: structure, function and evolution
P De Meyts
BIOESSAYS (2004)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
